- Johnson & Johnson (NYSE:JNJ) is in talks to purchase cardiovascular-focused medical technology company Shockwave Medical (NASDAQ:SWAV).
- The Wall Street Journal reported that a deal could come in weeks, though it could be scuttled if another bidder expresses interest.
- Shockwave (SWAV) has a market cap of ~$11B. It is up ~12% in Tuesday afternoon trading on the chatter.
- In its Q4 2023 financial results released last month, the company beat on both lines.
- In late February, Seeking Alpha analyst Myriam Alvarez issued a strong buy rating for Shockwave (SWAV) and explained why it stands out in the medical device sector.
Trending
- ‘I want to die “young” as late as possible,’ says 83-year-old triathlete doctor who reinvented himself after a midlife crisis
- 10 Israeli Soldiers Hospitalized After Wasp Swarm Attack
- Construction Partners posts strong Q2 amid high demand By Investing.com
- ZIM Integrated sails to top industrial gainer of week, Builders FirstSource sees loser tag
- US Marine Says 40% of Drones the IDF Has Shot Down Were Their Own
- Amprius Technologies doubles customer base, boosts revenue By Investing.com
- My 19-year-old son wants to get married so Uncle Sam will ‘kick in more scratch’ for his girlfriend’s financial aid. Is this a terrible idea?
- Meet the Doomsayers Waiting for the Economy to Crash